Skip to main content
High RiskFDAfda-F-2198-2017SALMONELLA CONTAMINATION

SJ TACO Net Wgt: 44.5 LBS INGREDIENTS: Spices including Chili Pepper, Garlic Powder, Sugar, Paprika***Wheat Flour***CONTAINS: SOY, WHEAT ...

Category
Units Affected
41
Recall Date
March 27, 2017
Issuing Agency
Hazard
Salmonella Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2198-2017.

During an internal investigation the firm discovered that an ingredient used in various spices may contain Salmonella.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2198-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Givaudan Flavours Corp or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2198-2017.

Givaudan Flavours Corp

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Givaudan Flavours Corp Recall FAQ

Givaudan Flavours Corp is the subject of a food safety report: SJ TACO Net Wgt: 44.5 LBS INGREDIENTS: Spices including Chili Pepper, Garlic Powder, Sugar, Paprika***Wheat Flour***CONTAINS: SOY, WHEAT .... The notice was published on March 27, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 41 units are potentially affected.